Anakinra in systemic juvenile idiopathic arthritis (soJIA) non responsive to antiTNF by Pontikaki I, Gerloni V, Gattinara M, Fantini F

Connect to this object online.

Relationship between delayed menarche and bone density in patients affected by juvenile idiopathic arthritis by Lurati A, Salmaso A, Teruzzi B, Gerloni V, Gattinara M, Fantini F

Connect to this object online.

Accuracy of preliminary remission criteria some JIA category by Fantini F, Salmaso A, Gerloni V, Gattinara M, Teruzzi B, Pontikaki I, Lurati A

Connect to this object online.

Efficacy of a second TNF blocker, when the first one failed, in patients with juvenile idiopathic arthritis (JIA) by Salmaso A, Lurati A, Pontikaki I, Gerloni V, Gattinara M, Teruzzi B, Fantini F

Connect to this object online.

Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data by Espada G, Pardeo M, Chaitow J, Brown D, Allen R, Zulian F, Zuber Z, Wulffraat N, Joos R, Dolezalova P, Burgos-Vargas R, Woo P, Schneider R, Ruperto N, Brunner H, De Benedetti F, Flato B, Gerloni V, Horneff G, Wright S, Kenwright A, Lovell D, Martini A

Connect to this object online.

8.5 Predictors of long-term outcome of Juvenile Dermatomyositis (JDM): a Multicenter, Multinational Study of 490 patients by Ferrari C, Trail L, Pilkington C, Maillard S, Cuttica R, Katsicas MM, Russo R, Bandeira M, Ferriani V, Oliveira S, Saad-Magalhaes C, Silva CA, Baca V, Burgos-Vargas R, Solis-Vallejo E, Alessio M, Alpigiani MG, Corona F, Falcini F, Gerloni V, Lepore L, Magni-Manzoni S, Zulian F, Ruperto N, Pistorio A, Felici E, Rossi F, Sala E, Martini A, Ravelli A

Connect to this object online.